[144] Cerence Inc. SEC Filing

Rhea-AI Filing Summary

Cerence Inc. (CRNC) reported a Form 144 notice showing a proposed sale of 77,994 common shares valued at $960,269.93, with an approximate sale date of 10/07/2025 on NASDAQ. The filing shows those shares were acquired as restricted stock from the issuer on 10/01/2025 and paid for on that date. The filing also discloses a recent sale by Jennifer Salinas of 64,784 common shares on 10/06/2025 for gross proceeds of $826,468.92. The notice includes the required attestation that the seller does not possess undisclosed material adverse information and follows Rule 144 procedures for proposed insider sales.

Positive

• Form 144 filed, indicating procedural compliance with Rule 144 for insider sales
• Acquired shares documented as restricted stock on 10/01/2025, showing clear acquisition record

Negative

• Insider selling activity (planned sale of 77,994 shares) could be viewed negatively by some investors
• Recent sale of 64,784 shares on 10/06/2025 produced $826,468.92, indicating near-term insider liquidity

Insights

Equity Markets Analyst

TL;DR: An insider Form 144 shows planned sale of 77,994 restricted shares for about $960K, filed under Rule 144.

The filing documents a proposed sale of 77,994 common shares with an aggregate market value of $960,269.93 and notes the shares were received as restricted stock from the issuer on 10/01/2025. It also records a near-term sale of 64,784 shares on 10/06/2025 generating $826,468.92 in gross proceeds.

These disclosures allow investors to see insider liquidity activity and confirm compliance with Rule 144 procedures. Watch trading dates around 10/06/2025–10/07/2025 for market impact and any further filings that report completed sales or plan details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	77994	960269.93	43319651	10/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock	ISSUER			77994	10/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JENNIFER SALINAS 25 Mall Road Suite 416 Burlington MA 01803	COMMON	10/06/2025	64784	826468.92

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Cerence (CRNC) Form 144 disclose?

The Form 144 shows a proposed sale of 77,994 common shares valued at $960,269.93 with an approximate sale date of 10/07/2025 on NASDAQ.

When were the shares to be sold by CRNC acquired?

The shares were acquired as restricted stock from the issuer on 10/01/2025 and payment is recorded on that date.

Did the filing report any recent sales by the same person?

Yes. The filing lists a sale by Jennifer Salinas of 64,784 common shares on 10/06/2025 for gross proceeds of $826,468.92.

Which exchange will the proposed CRNC sale take place on?

The Form 144 lists NASDAQ as the securities exchange for the proposed sale scheduled on 10/07/2025.

Does the filer attest to possession of material nonpublic information?

Yes. The person signing the notice attests they do not know any material adverse information about the issuer that has not been publicly disclosed.